Improving immune checkpoint therapy via Ab- and Glyco-targeting of melanoma stem cell-Tim-3
Date and Time
February 19, 2021
04:00PM - 05:00PM EST
Location
Via Zoom
HSCI Skin Program Spring Seminar Series (open to all members of the HSCI research community)
Join us at: https://partners.zoom.us/j/9240930305
Guest speaker:
Steven R. Barthel, PhD
Instructor in Dermatology
Brigham and Women's Hospital
Dr. Barthel’s interdisciplinary expertise and ongoing research in glycobiology, galectins, melanoma/skin cancer, cancer stem cells, signaling, metastasis and biomarkers underlies his overall career and research goals to (1) characterize carbohydrate mediators of cancer progression and immune diseases, (2) identify and develop therapies to treat and diagnose cancer and inflammation, and to (3) mentor/train the next-generation of researchers in cancer and immunology.